Ethamolin 5% ampul 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9Y29
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,437
Award facts
- Contract value 100% obligated
- $15,437.19 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has received a delivery order from the Defense Logistics Agency (DLA) valued at $15,437.19 for Ethamolin 5% ampules (2 mL vials). The award, issued on January 16, 2026, with an ultimate completion date of January 20, 2026, was made on a non-set-aside, competitively awarded basis under firm fixed-price terms. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications and medical supplies to military healthcare programs worldwide.
Ethamolin is a sclerosing agent used in medical procedures, representing one component of the extensive pharmaceutical portfolio that AmerisourceBergen delivers through its DLA contract vehicles. The company's parent organization, Cencora, Inc., maintains an even larger IDC with DLA valued at up to $999,999,999.00 through December 31, 2031, underscoring the organization's critical role in supplying pharmaceutical products and medical commodities to Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. AmerisourceBergen's continued award of delivery orders at varying values demonstrates its capability to meet federal procurement requirements through open competition across diverse medical supply needs.
Quick answers
Who was awarded contract SPE2DR26F9Y29?
SPE2DR26F9Y29 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 16, 2026.
How much is contract SPE2DR26F9Y29 worth?
The government has obligated $15,437 on SPE2DR26F9Y29.
Is contract SPE2DR26F9Y29 an order under another contract?
Yes. SPE2DR26F9Y29 is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F9Y29 competed?
The extent of competition for SPE2DR26F9Y29 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award